Rtw Investments, LP Regenxbio Inc. Transaction History

Rtw Investments, LP

$6.27 Billion
Q3 2024

A detailed history of Rtw Investments, LP transactions in Regenxbio Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 350,000 shares of RGNX stock, worth $2.67 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

350,000

Previous 350,000 -0.0%

Holding current value

$2.67 Million

Previous $4.09 Million 10.33%

% of portfolio

0.06%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.17 - $24.61 $4.26 Million - $8.61 Million	350,000 New	350,000 $7.37 Million
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $2.55 Million - $4 Million	87,623 Added 4.98%	1,845,366 $77.4 Million
Q2 2021 Aug 13, 2021	BUY	$32.46 - $40.48 $43.5 Million - $54.3 Million	1,341,166 Added 321.95%	1,757,743 $68.3 Million
Q1 2021 May 14, 2021	BUY	$33.61 - $49.95 $4.51 Million - $6.71 Million	134,317 Added 47.59%	416,577 $14.2 Million
Q4 2020 Feb 16, 2021	SELL	$26.52 - $49.35 $959,334 - $1.79 Million	-36,174 Reduced 11.36%	282,260 $12.8 Million
Q3 2020 Nov 16, 2020	BUY	$27.01 - $40.26 $64,986 - $96,865	2,406 Added 0.76%	318,434 $8.76 Million
Q2 2020 Aug 14, 2020	BUY	$27.75 - $43.44 $67,210 - $105,211	2,422 Added 0.77%	316,028 $11.6 Million
Q1 2020 May 15, 2020	BUY	$21.5 - $54.2 $171,892 - $433,329	7,995 Added 2.62%	313,606 $10.2 Million
Q4 2019 Feb 14, 2020	BUY	$34.54 - $44.87 $498,861 - $648,057	14,443 Added 4.96%	305,611 $12.5 Million
Q3 2019 Nov 14, 2019	SELL	$31.84 - $50.88 $2.45 Million - $3.91 Million	-76,872 Reduced 20.89%	291,168 $10.4 Million
Q2 2019 Aug 14, 2019	SELL	$42.0 - $59.29 $3.49 Million - $4.93 Million	-83,142 Reduced 18.43%	368,040 $18.9 Million
Q1 2019 May 15, 2019	SELL	$40.82 - $62.45 $24.5 Million - $37.4 Million	-599,063 Reduced 57.04%	451,182 $25.9 Million
Q4 2018 Feb 14, 2019	SELL	$39.11 - $75.15 $16 Million - $30.7 Million	-408,883 Reduced 28.02%	1,050,245 $44.1 Million
Q3 2018 Nov 14, 2018	SELL	$65.0 - $82.15 $40.3 Million - $51 Million	-620,427 Reduced 29.83%	1,459,128 $110 Million
Q2 2018 Aug 14, 2018	BUY	$27.2 - $74.35 $5.49 Million - $15 Million	201,788 Added 10.75%	2,079,555 $149 Million
Q1 2018 May 14, 2018	BUY	$24.05 - $37.5 $7.61 Million - $11.9 Million	316,557 Added 20.28%	1,877,767 $56.1 Million
Q4 2017 Feb 14, 2018	BUY	$26.0 - $34.6 $577,330 - $768,293	22,205 Added 1.44%	1,561,210 $51.9 Million
Q3 2017 Nov 14, 2017	BUY	$18.0 - $32.95 $27.7 Million - $50.7 Million	1,539,005	1,539,005 $50.7 Million

Others Institutions Holding RGNX

# of Institutions

196

Shares Held

43M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Account

Rtw Investments, LP Regenxbio Inc. Transaction History